The "Tumor targeting & radiotherapies network" of the Cancéropôle Grand-Ouest is pleased to announce its twelfth international workshop dedicated to young
researchers (PhD Students and Post-Docs), even so experienced researchers are invited to participate.
This workshop will be focused on
“Imaging and therapeutic targeting
in cancerology: New advances and trends in preclinical and clinical studies”
from the 26th to 29th of September 2018 in Le Bono, West of France.
Since several years, many different targeted therapies have been approved for use in cancer treatment like hormone therapies, signal transduction inhibitors, gene expression modulators, apoptosis inducers, angiogenesis inhibitors, immuno-therapies. This workshop will focus on delivery molecules as radiolabelled compounds, nanodrugs and antibody drug conjugates. It will explore how to identify the adequate tumour targets in the cell or in the tumour microenvironment, and the potential strategies to reach them. Moreover, we will be interested in follow-up of the targeting by imaging with a special attention to multimodality for imaging and therapy.
Presentations of biologists, chemists, pharmacists and physicians will cover advances in this field of cancer research.
30 travel grant awards are available for young researchers (PhD students and Post-Docs).
Program contents keynote presentations of internationally recognized researchers including:
- Patrick Couvreur, Galien Institute, Paris Saclay University, Chatenay Malabry, France
- Stefania Galdiero, Department of Pharmacy, University of Naples "Federico II", Italy
- Nathalie Labarrière, Nantes Angers Cancer and Immunology Research Center, France
- Rafael T.M. de Rosales, King's College London, St. Thomas' Hospital, United-Kingdom
- Alexander Satz, Roche, Switzerland
Overview lectures will be given by experts in the different scientific fields adressed by the workshop. A number of selected oral presentations given by young researchers will complete the different scientific sessions. This workshop aims at sharing scientific results and at facilitating exchanges between experienced and young researchers in a fast advancing field.
To stimulate intense discussions between young and senior scientists, the total attendance is limited to a maximum of 65 persons.
Deadline for abstract submission: May 18th
Registration deadline: June 15th
What is the tumour targeting and radiotherapies network of the Canceropôle Grand Ouest ?
The first "Plan Cancer" was launched in 2003 as an initiative to foster France's efforts in cancer management. One of the actions of the plan was the creation of 7 "Cancéropôles" with the mission of organizing cooperation in the field of translational research between laboratories and clinical departments within a geographic area. Thus the Cancéropôle Grand Ouest (CGO) was set-up, covering 3 of the 13 French Regions.
The CGO is now organized in 11 networks.
The "Tumour Targeting and Radiotherapies" network includes four interconnected research domains, which are:
- Concept of innovating agents and nanomedicines for imaging and therapeutic purposes,
- Targeted therapies and radiotherapies for cancer: from animal models to clinical trials,
- Quantitative multimodal imaging and radiotherapies,
- Biological response and targeted therapies.
This network is coordinated by Dimitris Visvikis, LaTIM, National Institute of Health & Clinical Sciences, Brest, France.
More information : http://www.canceropole-grandouest.com